A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Opis bibliograficzny
1. autor:	Bakar, Osama Bin Abu
Kolejni autorzy:	Yasmin, Hasina
Format:	Praca dyplomowa
Język:	English
Wydane:	Brac University 2024
Hasła przedmiotowe:	Alzheimer’s disease Neurological disorder Dementia FAERS database FDA adverse event reporting system Rhabdomyolysis Alzheimer's disease > Therapy Nervous System Diseases
Dostęp online:	http://hdl.handle.net/10361/23186

Podobne zapisy

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
od: Tabassum, Nadira
Wydane: (2024)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
od: Karmaker, Swastika
Wydane: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
od: Mahee, Sadique Abdal
Wydane: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
od: Jahan, Nusrat
Wydane: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
od: Shehab, Habibul Mohsin
Wydane: (2024)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
od: Ishrat, Nowshin
Wydane: (2024)

Role of circular RNA in neurological disease
od: Salsabil, Labiba
Wydane: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
od: Alim, Abdul
Wydane: (2023)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
od: Dey, Manashi
Wydane: (2024)

Potential treatments for epigenetic dysregulation in neurological diseases
od: Zaman, Rubaiyat
Wydane: (2024)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
od: Chowdhury, Sariya Uzrat
Wydane: (2022)

Emerging therapies of Alzheimer’s disease: a comprehensive review
od: Tasin, Md Abtahi
Wydane: (2023)

Gene editing for neurodegenerative diseases-A review
od: Sharna, Anika Islam
Wydane: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
od: Tasneem, Sadia
Wydane: (2021)

Role of protein’s and future treatment options for Alzheimer’s Disease
od: Islam, Md. Irfath
Wydane: (2023)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
od: Saha, Bithi Rani
Wydane: (2023)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
od: Tamanna, Mst. Taskia
Wydane: (2023)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
od: Hassan, Md. Muhtaz
Wydane: (2020)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
od: Mostofa, Golam
Wydane: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
od: Aana, Afsara Sumon
Wydane: (2021)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
od: Aziz, Farhin
Wydane: (2019)

Alzheimer's disease and marriage : an intimate account /
od: Wright, Lore K.
Wydane: (1993)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
od: Haque, Mushfiqul
Wydane: (2019)

A review on optogenetics and its potential in neurological disorder management
od: Armin, Fariza
Wydane: (2024)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
od: Afra, Sumaiya
Wydane: (2022)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
od: Halim, Rabea
Wydane: (2022)

Exploring Alzheimer's disease prediction with XAI in various neural network models
od: Rahman, Quazi Ashikur, i wsp.
Wydane: (2022)

Role of voltage-gated sodium channel modulators in peripheral nervous system disorders
od: Mithila, Sabekun Nahar
Wydane: (2023)

Marine compounds in the treatment of Alzheimer’s disease
od: Parveen, Sanjana
Wydane: (2022)

Skeleton /
od: Parkin, Peter

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
od: Khandker, Tahia Anjum
Wydane: (2024)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
od: Islam, Md. Rakibul
Wydane: (2023)

An ambient assisted living system for Alzheimer’s patients
od: Abedin, Minhajul, i wsp.
Wydane: (2023)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
od: Key, Nasrin Sultana
Wydane: (2023)

Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
od: Onanna, Kazi
Wydane: (2024)

Oral terbinafine-, fluconazole-, ravuconazole-, oteseconazole-induced hepatotoxicity and acute kidney injury in the treatment of onychomycosis: a pharmacovigilance study
od: Rahman, Towsifur
Wydane: (2024)

A review on adult neurogenesis in Alzheimer’s disease
od: Akter, Moriam
Wydane: (2022)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
od: Roy, Aditya, i wsp.
Wydane: (2023)

Status of cognitive decline in post covid-19 Bangladeshi patients
od: Bapan, Pranta Saha
Wydane: (2024)

The illness narratives : suffering, healing, and the human condition /
od: Kleinman, Arthur
Wydane: (1988)